Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | MMP9 | P14780 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | EGFR | P00533 | 2/20 | 0.41 |
| ▸ | FYN | P06241 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CA4 | P22748 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4240965 | 0.82 | — | — | |
| SCHEMBL11771165 | 0.78 | IDO1 (0.31) | — | |
| SCHEMBL4651553 | 0.76 | CA2 (0.40) | CA2ALDH1A1LMNANPC1HSD17B10 | |
| SCHEMBL11554645 | 0.73 | CXCR2 (0.57) | CA2ALDH1A1LMNANPC1HSD17B10 | |
| SCHEMBL5144816 | 0.73 | TSHR (0.35) | ALDH1A1LMNANPC1HSD17B10MAPT | |
| SCHEMBL28453796 | 0.71 | RAPGEF4 (0.39) | CA2ALDH1A1NPC1MAPTHPGD | |
| SCHEMBL22584770 | 0.70 | CXCR2 (0.53) | CA2ALDH1A1LMNANPC1HSD17B10 | |
| SCHEMBL1952571 | 0.67 | IDO1 (0.43) | CA2ALDH1A1LMNANPC1HSD17B10 | |
| SCHEMBL11648181 | 0.66 | NPC1 (0.53) | CA2ALDH1A1LMNANPC1HSD17B10 | |
| SCHEMBL304891 | 0.66 | CXCR2 (0.54) | CA2ALDH1A1LMNANPC1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6380386-B2 | INSECTICIDES, BACTERICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2002-04-30 | — | — | US | disclosed |
| US-20020006958-A1 | Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2002-01-17 | — | — | US | disclosed |
| US-6194418-B1 | Substituted aminosalicyclic acid amides with fungicidal effect and intermediate products for production thereof | BAYER AKTIENGESELLSCHAFT (DE) | 2001-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020006958-A1 | Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof | AADAC, DDC, DAO | CA2 308/4885ALDH1A1 353/4885LMNA 4269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.